MKI67 and skin squamous cell carcinoma: IVIM-DWI combined with TA based on IVIM-DWI can noninvasively predict the Ki-67 PI in CSCC before surgery, which has important clinical value in detecting high-risk patients, predicting the therapeutic effect, and judging the prognosis of patients.